CEO
Angelini Pharma appoints Sergio Marullo di Condojanni as CEO
February 4, 2026Angelini Pharma, CEO
Angelini Pharma, a branch of Angelini Industries, has announced the appointment of Sergio Marullo di Condojanni as CEO. Marullo di …
Alvotech appoints Lisa Graver as CEO
February 3, 2026Alvotech, CEO
Alvotech has announced the appointment of Lisa Graver as CEO, following the retirement of Róbert Wessman. Wessman served as Chairman …
Pace appoints Ken Beyer as CEO
December 10, 2025CEO, Pace Analytical
Pace, a science and technology company specialising in environmental and life sciences laboratories, has announced the appointment of Ken Beyer …
ViVac Pharma appoints Keren Leshem as CEO
November 26, 2025CEO, Oncology, ViVac Pharma
Early-stage biotechnology company ViVac Pharma has appointed Keren Leshem as its new CEO. Leshem brings almost 30 years of experience …
PolyNovo welcomes Bruce Peatey as CEO
October 22, 2025CEO, Market Expansion, PolyNovo, medtech, wound care
PolyNovo, an Australian medtech company specialising in acute complex wound management, has appointed Bruce Peatey as its new chief executive …
Sanner appoints new CEO to drive CDMO strategy
August 11, 2025Contract Manufacturing, Manufacturing and Production CEO, Corporate, Sanner, contract development and manufacturing organisation
German packaging solutions company, Sanner, has announced a significant leadership change as it advances its transformation into a contract development …
Aragen appoints Aniel Khubchandani as CEO of development and manufacturing solutions division
August 8, 2025Manufacturing Services, Manufacturing and Production Aragen Life Sciences, CEO, Corporate, development and manufacturing solutions, manufacturing services
Aragen Life Sciences, based in Hyderabad, India, has appointed Aniel Khubchandani as CEO of its development and manufacturing solutions (DMS) …
Cube Biotech appoints Michael Bencak as new CEO amid global expansion plans
July 25, 2025Mergers and Acquisitions, Research and Development CEO, Corporate, Cube Biotech, IBA Lifescience, archimed, executive chairman
Cube Biotech has announced a leadership transition as the company continues its trajectory of global growth and innovation in protein …
Jazz Pharmaceuticals appoints Renée Galá as CEO to lead next phase of growth
July 16, 2025Research and Development CEO, Corporate, Neurology, Oncology, jazz pharmaceuticals, neurology, neuroscience
Jazz Pharmaceuticals has named Renée Galá as its next chief executive officer (CEO), effective 11 August 2025. Galá, currently president …
Norstella appoints Kris Joshi as CEO to drive next phase of growth
July 10, 2025Business Services, Consultancy CEO, Corporate, HealthTech, Norstella
Pharma intelligence solutions provider, Norstella, has appointed health-tech leader, Kris Joshi, as its new chief executive officer (CEO) with former …
Nick Challoner appointed CEO of Ingenza to drive further growth
July 4, 2025Business Services, Manufacturing and Production CEO, Corporate, Ingenza, contract research development and manufacturing organisation (CRDMO), president
Ingenza, a Scottish contract research, development and manufacturing organisation (CRDMO), has announced the appointment of Nick Challoner as chief executive …
Ochre Bio appoints Quin Wills as CEO to lead next phase of liver therapeutics development
June 30, 2025Research and Development Boehringer Ingelheim, CEO, GSK, Hepatology, Ochre Bio, RNA therapeutics, chronic liver disease, clinical genomics
Oxford-based biotechnology company Ochre Bio has announced the appointment of Quin Wills as CEO. As co-founder of the company and …
Opterion Health strengthens board with appointments of Rice Powell and Mark Hahn
June 25, 2025Research and Development CEO, Nephrology, Opterion Health, board of directors, cfo, chronic kidney disease, dialysis solution
Swiss life sciences company Opterion Health has appointed two senior industry figures to its board of directors: Rice Powell, former …
MC2 Therapeutics appoints Trine Ahlgreen as new CEO
May 27, 2025Research and Development, Sales and Marketing CEO, Corporate, MC2 Therapeutics, Skin, inflammatory skin conditions
MC2 Therapeutics, a Danish pharma company focused on topical therapies for inflammatory skin conditions, has appointed Trine Ahlgreen as CEO. …
Tozaro appoints Jason Slingsby as CEO to lead commercial strategy in cell and gene therapy sector
May 1, 2025Manufacturing Services, Manufacturing and Production, Research and Development CEO, CGT, Jason Slingsby, Michele Pedrocchi, Pharmacy, Tozaro, manufacturing
Tozaro, a technology provider specialising in cell and gene therapy (CGT) manufacturing, has appointed Jason Slingsby (pictured left) as its …
